Document is current
Any future updates will be listed below
-
Authors
Incorvaia, Lorena
Scagliarini, Sarah
Marques Monteiro, Fernando Sabino
Takeshita, Hideki
Tapia, Jose Carlos
Gandur Quiroga, María Natalia
Lam, Elaine
Tural, Deniz
Popovic, Lazar
Campos-Gomez, Saul
Zucali, Paolo Andrea
Mota, Augusto
Ortega, Cinzia
Sade, Juan Pablo
Rizzo, Mimma
Fiala, Ondřej
Vau, Nuno
Giannatempo, Patrizia
Abahssain, Halima
Galosi, Andrea Benedetto
Badalamenti, Giuseppe
Kopecky, Jindrich
Bamias, Aristotelis
Landmesser, Johannes
Ansari, Jawaher
Calabrò, Fabio
Massari, Francesco
Buti, Sebastiano
Bellmunt, Joaquim
Santoni, Matteo
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 4 March 2025
First Online: 14 March 2025
Declarations
:
: Dr. Buti reported receiving personal fees from BMS, Pfizer, MSD, Ipsen, Roche, Eli Lilly, AstraZeneca, Pierr e-Fabre, Novartis, Merck, Gentili, and Astellas outside the submitted work; Dr. Fiala reported receiving personal fees from Novartis, Janssen, Merck, BMS, MSD, Pierre Fabre and Pfizer outside the submitted work; Dr. Incorvaia reported receiving personal fees from Bristol Myers Squibb and IPSEN outside the submitted work; Dr. Massari reported receiving personal fees from Advanced Accelerator Applications, Astellas, Astra Zeneca, Bayer, BMS, Janssen, Ipsen, MSD, Pfizer outside the submitted work. The other authors have no competing interests to declare.
